Software teams are under pressure to release faster.
A new feature cannot always wait three months for a traditional release cycle. Cloud applications change frequently, integrations are updated, and business teams expect improvements quickly.
But pharmaceutical companies have another responsibility.
The system still has to be controlled.
That is where DevOps and Computer System Validation (CSV) can sometimes appear to be on opposite sides.
DevOps wants speed.
CSV wants evidence.
Pharma needs both.
And the good news is that they do not have to work against each other.
The old question is changing
For years, validation was often treated as something that happened after software development.
Develop the application.
Freeze the version.
Prepare validation documents.
Execute testing.
Approve the release.
Move to production.
That approach can become difficult when software is being changed continuously.
A DevOps environment may involve frequent code changes, automated builds, automated testing and regular deployments.
Waiting until the end of a long development cycle to think about validation can create a bottleneck.
It can also create unnecessary rework.
The better question is not:
“How can we slow DevOps down so that CSV can keep up?”
It is:
“How can validation become part of the development and release process?”
This is where the GxP conversation becomes important
DevOps does not remove the need for validation.
It changes when and how validation activities are performed.
ISPE’s GAMP 5 Second Edition recognizes evolving software development approaches, including iterative and incremental methods, and also highlights increased use of software tools and automation throughout the system lifecycle.
That is important for pharma companies adopting Agile and DevOps.
Instead of treating validation as one large activity at the end, organizations can build appropriate controls into the lifecycle.
For example, automated testing can help identify defects earlier. Requirements and test evidence can be maintained through controlled tools. Changes can be assessed based on their GxP impact rather than automatically treating every software update in exactly the same way.
The objective is not more documentation.
The objective is appropriate assurance and evidence.
What does a DevOps CSV process actually look like?
Consider a LIMS application.
A development team changes a calculation function.
In a traditional setup, someone may discover the change later and begin a separate validation assessment.
In a better-controlled DevOps environment, the change can trigger defined activities:
Change → Impact Assessment → Automated/Targeted Testing → Review → Evidence → Release
The exact level of testing depends on the system, process risk and change.
A minor technical change should not automatically receive the same treatment as a change affecting a critical GMP calculation.
That is where risk-based Computer System Validation becomes valuable.
Automation can help—but it doesn’t make the decision
This is one area where organizations sometimes get confused.
A pipeline can execute hundreds of tests.
It can generate reports.
It can store results.
It can flag failures.
That’s useful.
But automation does not decide whether a change is acceptable for a GxP process.
Someone still needs to understand:
What changed?
What could the change affect?
What evidence is required?
Is the system still fit for intended use?
That human judgment remains important.
GAMP 5 also emphasizes applying critical thinking and using risk to determine appropriate verification and testing activities.
Where companies usually struggle
The difficult part is often not DevOps itself.
It is the connection between IT, development, QA and validation.
Developers may think in terms of code and deployments.
QA may focus on quality and compliance.
CSV teams think about requirements, traceability, testing and validation status.
If these teams work separately, every release can become a negotiation.
If they work from one agreed process, releases can become much smoother.
This is particularly important for cloud applications, LIMS, MES, QMS and other GxP computerized systems where software may change regularly.
What should pharma companies look at?
Before introducing DevOps into a validated environment, companies should consider:
Change management — How are software changes identified and assessed?
Testing strategy — Which tests can be automated, and which require human review?
Traceability — Can requirements, changes, tests and results be connected?
Evidence — Can the organization demonstrate what was tested and why?
Access control — Who can modify code, configurations and deployment pipelines?
Validation status — How is the validated state maintained after repeated releases?
These controls help connect development speed with GxP compliance and data integrity.
The opportunity for pharma companies
DevOps does not have to mean choosing between speed and compliance.
With the right approach, companies can reduce repetitive manual work, detect problems earlier and make validation activities more closely aligned with actual risk.
That’s also why modern CSV requires more than documentation skills.
It requires an understanding of software development, testing, change management, automation and the regulated business process.
At SkillBee Solution, we support pharmaceutical organizations with Computer System Validation (CSV), risk assessment, validation lifecycle management, testing support, cloud system validation, LIMS validation and audit readiness.
For companies working across Bengaluru, Hyderabad and other locations, our focus is to help connect technology implementation with practical GxP compliance.
Faster releases are possible.
But in pharma, the goal isn’t simply to release software quickly.
It is to release it with the right controls, the right evidence and the right level of assurance.
That is where DevOps and CSV can work together.
SkillBee Solution
81036-35949
info@skillbee.co.in
skillbee.co.in